Wednesday 11 July 2012

Peptide therapeutics is evolving as a promising field over the past few years as a result of continuous research and developments in the field for developing new and effective drugs. New delivery techniques and manufacturing technologies coupled with intensified research and development programs is resulting in the approval of new peptide based drugs. 

Peptide therapeutics is the best option in recombinant medicines due to their low toxicity, high specificity, and much lower molecular weight which makes it easier to prepare dosage plans for patients. Improvements in manufacturing process and delivery systems are triggering the growth of this industry. 

Many large pharmaceutical companies are funding research and developments in this field which is further creating new opportunities for development of this industry. Emerging sectors of this industry like anti-infectives, vaccines, and central nervous system targeting peptides are well set for development of a new class of drugs. 
 

Market Segmentation

Segmentation Based on Product
  • Anticancer Peptides 
  • Receptor Interacting Peptides
  • Anti-Microbial Peptides
  • Antiviral
Peptide therapeutics market analyzes this market based on its market segments and geographies covered. Major geographies analyzed under this research report include 
  • North America 
  • Europe 
  • Asia Pacific 
  • Rest of the World 
This report includes comprehensive analysis of current trends in market, industry growth drivers, factors affecting market growth, market structure, and industry projections for upcoming years. This report also includes detailed analysis of technological improvements in the field, Porter’s five force model analysis, and complete company profiles of top industry players. 

The report provides review of micro and macro factors significant with respect to new entrants and existing market players with value chain analysis. 

Major Players 

Some of the major players dominating this market are Affymax, Amylin Pharmaceutical Inc, AM-Pharma, Angstrom Pharmaceuticals, Argolyn Biosciences, Demegen, Enanta Pharmaceuticals, Helix Biomedix, Jerini Pharmaceuticals, PPL Therapeutics, ProCyte Corporation, Targeted Molecule Corporation, Theratechnologies, Zengen Inc, and others. 

Reasons for Buying this Report 
  • This research report provides overview of major market forces driving and restraining market growth 
  • It provides clear understanding of changing competitive dynamics and keeps you ahead of competitors
  • Report provides technological growth map over time and explains its impact on market 
  • It helps in making informed business decisions by making in-depth analysis of market 
  • It provides distinctive graphics and exemplified SWOT analysis of major industry segments 
  • Report provides detailed analysis of major competitors and their strategies 
  • It also provides up-to-date analysis of latest trends in market and helps you stay updated with recent technological improvements.
Inquire before Buying OR Buy your copy of this report @:
http://www.transparencymarketresearch.com/peptide-therapeutics-market.html
The global market for synthetic biology is estimated to grow to $4.5 billion over the year 2015 owing to the developments in fields like biomedicine, biopharmaceutical synthesis, energy and environment, biosecurity, sustainable chemical segment, and biomaterials. Significant investments by major companies and emergence of new players in the market are also expected to boost the growth of this industry. 

Synthetic biology is the fastest growing segment of the biotechnology field having number of applications. Synthetic biology provides significant number of near future commercial opportunities. Despite its emerging status, the list of applications is continuously growing. Some of these major applications include chemicals, enzymes, synthetic genes and other DNA parts, pharmaceuticals, biofuels, and chassis microorganisms among others.

Current developments in technologies like DNA synthesis and sequencing, specialty media, and bioinformatics, and the need for renewable feedstock are driving the market for synthetic biology. Rapid developments in this field are creating unique market opportunities and contributing to the growth of this field. 

Synthetic biology is gaining tremendous recognition as a transformative technology as it has the ability to address food storage and security issues as well as handle other threats like climate change, energy shortage, and water deficits. 
 

Market Segmentation

Application Segments 
  • Energy and Chemicals
  • Biotechnology and Pharmaceuticals 
  • Research and Development
Market Segments 
  • Enabling Products
  • Biologic Components
  • Integrated Systems 
  • Enabled Products
The research report on the synthetic biology market analyzes this market depending on its market segments and major geographies. The geographies analyzed under this research report are
  • North America
  • Europe
  • Asia Pacific 
  • Rest of the World 
This research report is a comprehensive analysis of current industry trends, industry growth drivers, restraints, industry capacity, market structure, and market projections for upcoming years. The report also includes analysis of technological developments in the market, Porter’s five force model analysis, and complete company profiles of top industry players. 
It provides review of micro and macro factors significant with respect to new entrants and existing market players with value chain analysis. 

Major Players 

Major players dominating this market are Amyris Biotechnologies Inc., ATG Biosynthetics GmbH, Blue Heron Biotechnology Inc., Chromatin Inc., Draths Corp., febit Synbio GmbH, GENEART AG, GenScript USA Inc., Joule Biotechnologies Inc., LC Sciences, LS9 Inc., OPXBIO Inc., Solazyme Inc., Sloning BioTechnology GmbH, Synthetic Genomics Inc., Verdezyne Inc, and others.
 
Reasons for Buying this Report 
  • The report provides distinctive graphics and exemplified SWOT analysis of major industry segments 
  • It provides pin-point analysis of changing competition dynamics and keeps you ahead of competition 
  • This research report provides forward looking perspectives on major market forces responsible for driving and restraining market growth
  • It provides comprehensive analysis of major competitors and their strategies 
  • It provides up-to-date analysis of current market trends and keeps you updated with technological changes in industry 
  • Report provides clear understanding of key product segments and competitive environment 
  • It provides technological growth map over time and explains its impact on industry.
Inquire before Buying OR Buy your copy of this report @:
http://www.transparencymarketresearch.com/synthetic-biology-market.html
The global regenerative medicines market is forecasted to reach the market value of $1.4 billion over the year 2015 powered by increasing focus on stem cell research, aging baby boomers, greater usage of non-autograft products, and increasing investments in research and development activities. 

Regenerative medicine industry is assumed to be the next generation technology to revolutionize the medical system in the upcoming years. This industry is still in growing stage in terms of commercial applications, with a number of available products being limited to the field of orthopedics. A majority of products in other therapeutic fields are in preclinical or early clinical assessment stage. Support from governments around the world and technological breakthroughs are expected to drive the market growth for the regenerative medicines industry. 

Aging population with various age related cell dysfunctions provide a ready market for new therapies based on tissue engineering and regenerative medicines. Advancements in biological sciences are drastically impacting the regenerative medicine market in a positive way. Growing awareness about the use of regenerative medicines and increasing usage of non-autograft products is stimulating the growth of this market. Also, rising investments in research and development activity and improvements in regenerative equipments is further propelling the growth of this market. 
 

Market Segmentation
  • Tissue Engineering
  • Stem Cell Therapy
  • Nanoscience
  • Bioengineering 
Application Segments 
  • Cardiovascular Diseases
  • Diabetes
  • Cancer
  • CNS Diseases
  • Eye Diseases
Regenerative medicines market analyzes this market depending on its segments and major geographies. Geographies analyzed under this research report are
  • North America 
  • Asia Pacific
  • Europe
  • Rest of the World 
This report includes comprehensive analysis of 
  • Current market trends
  • Industry growth drivers
  • Restraints 
  • Market structure 
  • Market projections for the near future 
This report also includes detailed analysis of technological improvements in the field, Porter’s five force model analysis, and complete company profiles of top industry players. 
The report provides review of micro and macro factors significant with respect to new entrants and existing market players with value chain analysis. 

Major Players 

Some of the major players dominating this market are Aastrom Biosciences Inc., Advanced Cell Technology Inc., Athersys Inc, Amgen Inc., Bioheart Inc., Cytori Therapeutics Inc., Celgene Corporation, Geron Corporation, Genzyme Corporation, Osiris Therapeutics, Japan Tissue Engineering Co. Ltd., ThermoGenesis Corporation, and others. 

Reasons for Buying this Report 
  • Report provides technological growth map over time and explains its impact on market 
  • It helps in making informed business decisions by making in-depth analysis of market 
  • It provides distinctive graphics and exemplified SWOT analysis of major industry segments 
  • It also provides up-to-date analysis of latest trends in market and helps you stay updated with recent technological improvements 
  • It provides clear understanding of changing competitive dynamics and keeps you ahead of competitors
  • This research report provides overview of major market forces driving and restraining market growth 
  • Report provides detailed analysis of major competitors and their strategies.
Inquire before Buying OR Buy your copy of this report @:
http://www.transparencymarketresearch.com/regenerative-medicines-market.html

Wednesday 4 July 2012

Radio frequency identification (RFID) is a wireless technology becoming widely popular in various applications. RFID technology employed in healthcare settings may help in keeping track of medical staff’s compliance with policies to inventories they use. Staff tracking measures is the most common application of RFID technology; however, this technology is used in number of other applications in healthcare sector. 

RFID technology involves use of small ‘tag’ devices that radiates radio signals which are received by RFID receivers. This tag is read when it is in the range of the receiver (reader). Information is managed by a computer and it allows the user to interact with the data. As this technology does not involve data entry operations and they enhance mobile healthcare industry, this market is expected to witness significant growth in the coming few years. 
 
To BUY This Report Kindly Visit Us @:

With nearly two million people developing hospital acquired infections annually, hand washing compliance is emerging as one of the major application sectors for RFID devices. When the staff member approaches the soap dispenser, the RFID system will read the RFID encoded badge and record the details of the person in the system. Owing to its increasing use in healthcare industry, the global market for RFID in healthcare is expected to grow at the compounded annual growth rate of 29.6% during the forecasted period. RFID sensors are used for tracking sleep pattern of patients; RFID is also used in security applications in the healthcare and pharmaceutical industry. 
 
Market Segmentation
  • Pharmaceutical/Blood Product Distribution and Tracking 
  • Patient/Medical Staff Identification and Tracking 
  • Medical Asset Tracking and Locating 
  • Implantable Device RFID use 
Other areas (including medical documents and patient records)
The research report on the global market for RFID in healthcare analyzes the RFID market based on its market segments and major geographies. Geographies analyzed under this research report include 
  • North America
  • Asia Pacific 
  • Europe
  • Rest of the World 
This report provides comprehensive analysis of current market trends, market growth drivers, factors limiting market growth, market structure, and market projections for upcoming years. The report also provides analysis of recent developments in technology, Porter’s five force model, and complete company profiles of top industry players. It includes review of micro and macro factors significant with respect to existing market players and new entrants with value chain analysis. 

Major Players 

Some of the key players dominating this market are 3M, Alien Technology, Blue Vector, Hewlett-Packard, International Business Machines (IBM), Intermec Inc., Motorola, PositiveID, Solstice Medical, SupplyScape, Tagsys Inc., Versus Technology, Zebra Technologies, and others. 

Reasons for Buying this Report 
  • The report provides technological growth map over time and explains its impact on industry 
  • It provides distinctive graphics and exemplified SWOT analysis of major industry segments 
  • The report provides complete analysis of major competitors and their strategies
  • It provides clear understanding of key product segments and competitive environment 
  • The report provides pin-point analysis of changing competition dynamics and keeps you ahead of competitors
  • This research report provides forward looking perspectives on major market forces driving and restraining market growth 
  • It helps in making informed business decisions by having complete insights of the market and by making in-depth analysis of industry trends.
For more information kindly visit:
http://www.transparencymarketresearch.com/rfid-in-healthcare.html